In five glaucoma patien� a previous filtering surgery that was followed by sub conjunctival injections of 5-Fluorouracil (5-FU) failed, due to filtering bleb scarring.
6-19 months of follow-up, lOP levels in all five eyes were 20 mmHg or less with medi cation. A repeated course of filtering surgery plus 5-FU'treatment seems to be a favourable surgical option in refractory glaucoma. 
Materials and Methods
Five eyes of five patients were studied. (Table) .
Patients were examined daily in the first week, twice to seven times in the second week, once in the third and fourth weeks, and again after the second, third, fourth, sixth, eighth, tenth and twelfth months. (Table) . Whereas pre-operatively all five eyes were treated by four hypotensive medi cations, a mean of 2.2±1.3 medications were given post-operatively. Side-effects included punctate corneal ero sions in two (40%) eyes (Table) and conjunc tival epithelial defects at the injection site in three (60%) eyes.
Results

5-FU administration post-operation ranged
Discussion
A repetition of filtering surgery followed by 5-FU treatment was performed in three pseudophakic glaucomous eyes, as a third fil tering operation in one other eye, and a fourth filtering operation in a fifth eye. In all five eyes, lOP level� after six to 19 months fol low-up were 20 mmHg or lower, all with hypo tensive medication. Several theoretical reasons can be postulated for the success rate of the second rather than the first course of fil tering surgery and 5-FU treatment. Among the possible explanations are undetectable bleeding or significant inflammation in the surgical area that promote scarring8•9 and lack of compliance Of patients following the first operation.
The accepted options following failure of filtering surgery plus 5-FU treatment are aqueous shunt implantation or a cyclodestruc tive procedure, but both are probably more risky than the approach presented in this Krupin and associates 7 implanted a long Krupin-Denver valve attached to a 1800 scleral explant in eyes in which prior filtration surgery had failed. After follow-up of 21 months (mean) lOP was less than 21 mmHg in 82% (27/33) of eyes; 56% of these eyes required additional medication. However, post-operative choroidal detachment with associated reduction in lOP and shallowing of the anterior chamber frequently occurred (11/33 of eyes = 33%). In eyes with a flat anterior chamber, the tube contacted the cor nea or lens.
The effectiveness of cyclocryotherapy in lowering lOP to avoid further surgery is reported as between 30-60% (11112) depend ing on the type of refractory glaucoma being treated. The complications of cyclotherapy are well documented and include choroidal detachment with a flat anterior chamber, phthisis bulbi, loss of light perception, sym pathetic ophthalmia, scleral thinning with resulting staphyloma, hyphaema, iritis, cor neal oedema, iris atrophy, retinal detach ment, cataract and vitreous haemorrhage. Brindley and Shields reported that after cyclocryotherapy, 60% of the eyes lost some vision with a phthisis bulbi rate of 12% (13) .
The significant risks of phthisis and visual loss with cyclocryotherapy have led to the development of other techniques of cilioabla tion such as Neodymium:YAG cyclophoto coagulation (Nd:YAG-CPC), argon laser transpupillary or transiridectomy cyclophoto coagulation and therapeutic ultrasonogrpahy. It is the higher rate rather than the type of complications reported that distinguishes cyclocryotherapy from Nd: YAG_Cpc.14 Trope and Ma15 reported that 30% of 28 eyes with good lOP control lost some vision after Nd:YAG-CPC, and the phthisis bulbi rate was 10.7%. Although this procedure appears to be effective, it is asociated with sig nificant complications.
Serious complications have also been described after the use of trans scleral ruby laser cyclocoagulation.16 Currently, there are no studies comparing Nd:YAG-CPC or other forms of therapy, including cyclotherapy, to trabeculectomy with injections of antimetabolites.
First-time course of filtering surgery and 5-FU was only rarely accompanied by per manent complications, 1.4 unless this treatment was administered in eyes with pre-operative bullous keratopathi7 or corneal oedema. 1 The second course of surgery with 5-FU was undertaken as early as three months after the preceding course (Case No. 5) and as late as seven months after the preceding course (Case No. 4). Side-effects following the second course of filtering surgery and 5-FU treatment reported here, were similar to those reported after a first course.1-4 Neither serious side-effects nor permanent complica tions were observed following the second use of s.c. 5-FU reported here.
The small sample presented here precludes significance, however the results may have clinical importance: in the five poor-prognosis glaucomatous eyes, lOP levels were 20 mmHg or lower, although all with hypoten sive medication. In addition, from this pre liminary study it does seem that a second course of filtering surgery plus 5-FU treat ment is safer than the alternatives mentioned above. A larger number of patients is needed to verify the results of this study.
